ICMR Transfers Homegrown Cervical Cancer Treatment Tech to Pharma Firms

The Indian Council of Medical Research (ICMR) announced today that it has transferred its home‑grown technologies for cervical pre‑cancer treatment and vaccine development to several pharmaceutical firms. The move is intended to accelerate the production of affordable, locally manufactured solutions for women across the country. By leveraging ICMR’s research, the pharma partners aim to bring the treatments to market faster and reduce dependence on imported products. The transfer underscores India’s growing capacity in medical innovation and its commitment to improving women's health outcomes.